WayPoint Biomedical Holdings, Inc.
WYPH
Other OTC0.00
USD
- -
- -
WayPoint Biomedical Holdings, Inc.
WYPH
(Other OTC)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- WayPoint Biomedical Holdings, Inc. (WYPH) develops and markets diagnostic tests and devices for screening and monitoring human health, fitness, and environmental hazards through its wholly owned subsidiary, WayPoint Biomedical, Inc.; core products include the Drink Detective drink spiking test that detects date rape drugs such as Ketamine, GHB, and Benzodiazepines; Health Essist tests for cocaine and marijuana detection; topical transdermal patches under the Health Essist brand, including Hangover-Free and Energy-Boost Power Patch lines; and Frontline Explosive Test Kits for detecting explosive residues, biowarfare agents, bioterrorism threats, and weapons of mass destruction. The company targets over-the-counter diagnostic self-testing, point-of-care diagnostics, homeland security, and defense markets primarily in the United States. Founded in 2004 and headquartered in Huntington Beach, California, with prior addresses in Torrance, California, WayPoint Biomedical Holdings operates in the health care equipment industry. In a significant recent development, on April 29, 2025, new management assumed control pursuant to a Nevada court order appointing John Richer as Custodian to reinstate corporate status, protect shareholder interests, and restore compliance with the Nevada Secretary of State following prior operational inactivity.